Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.
about
BTS Guidelines for the Management of Community Acquired Pneumonia in AdultsMacrolide resistance conferred by base substitutions in 23S rRNA.Chlamydia pneumoniae infections in asthma: clinical implications.Single-dose azithromycin for respiratory tract infections.Mycoplasma pneumoniae and its role as a human pathogen.Clinical applications of azithromycin microspheres in respiratory tract infectionsFastidious intracellular bacteria as causal agents of community-acquired pneumonia.Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.Outbreak of invasive infections from subtype emm26.3 group A Streptococcus among homeless adults-Anchorage, Alaska, 2016-2017.Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study.[Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions].Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients: A Systematic Review and Meta-Analysis.
P2860
Q24675547-21FDE69B-0F10-420E-91A3-BFA28AE4091FQ34106180-72ADF145-4D4C-4F45-BA4B-FA7B3C720942Q35627745-25B78DA5-63CC-4C81-A36B-694E19864835Q35670035-48AA6EDE-B5F1-4838-B4D6-1CA8CD29B93CQ35920629-74250BE1-532F-40D5-A8CE-AB6DCD657ECCQ37059889-FC9AE492-F254-46F5-A6D9-7FC4DCE2BFCFQ37768416-33566EB2-B15D-4036-A1D7-92122FC812AEQ39831380-F9CFE314-BCF2-4FC5-B65F-FBE7E3615C2CQ43167954-E74FA20C-B2FE-45C5-B8F1-C3DBF6007505Q46908696-4DC4B534-C1B6-44FA-A78D-24A5E1E6861AQ46986953-D3B6FDEC-D0BB-4D43-AE3C-DF4737EA0480Q47646167-376A5C41-2E09-4737-B77A-F85EE861DC8F
P2860
Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@en
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@nl
type
label
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@en
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@nl
prefLabel
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@en
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@nl
P2093
P2860
P356
P1433
P1476
Azithromycin: single 1.5 g dos ...... syndrome--a randomized study.
@en
P2093
Bozinović D
Oresković K
Radosević S
Schönwald S
P2860
P2888
P304
P356
10.1007/BF02561528
P577
1999-05-01T00:00:00Z